Showing 9021-9030 of 20381 results for "".
- Understanding Gestational Diabetes Management Through Patient Experiences: A Qualitative Insighthttps://reachmd.com/news/understanding-gestational-diabetes-management-through-patient-experiences-a-qualitative-insight/2484517/A recent qualitative study involving 32 women with gestational diabetes mapped experiences from diagnosis through postpartum and identified actionable gaps in care. These fin
- Schizophrenia and Aging May Share a Common Biological Basis: Genetic Changes in 2 Types of Brain Cellshttps://reachmd.com/news/schizophrenia-and-aging-may-share-a-common-biological-basis-genetic-changes-in-2-types-of-brain-cells/2457448/Credit: Pixabay/CC0 Public Domain Researchers from the Broad Institute of MIT and Harvard, Harvard Medical School, and McLean Hospital have uncovered a strikingly similar suite of changes in gene activity i
- Emerging Biomarkers in Diabetic Retinopathy: The Potential Role of Pentraxin 3 and Stress Hyperglycemia Ratiohttps://reachmd.com/news/emerging-biomarkers-in-diabetic-retinopathy-the-potential-role-of-pentraxin-3-and-stress-hyperglycemia-ratio/2475732/Subclinical microvascular injury in patients with diabetes often goes unnoticed until vision is compromised, underscoring an urgent need for diagnostic tools that detect early retinal changes and preserve quality of life through timely i
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://reachmd.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2474516/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick skin types
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://reachmd.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2475350/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick skin types
- New AI Tool Accurately Detects 6 Different Cancer Types on Whole-Body PET/CT Scanshttps://reachmd.com/news/new-ai-tool-accurately-detects-6-different-cancer-types-on-whole-body-petct-scans/2467008/June 10, 2024 Toronto, Ontario—A novel AI approach can accurately detect six different types of cancer on whole-body PET/CT scans, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting. By automatically q
- Algorithm Helps Doctors Identify More Aggressive Types of Basal Cell Carcinomahttps://reachmd.com/news/algorithm-helps-doctors-identify-more-aggressive-types-of-basal-cell-carcinoma/2467806/A newly developed algorithm can assist healthcare professionals in identifying patients with a highly aggressive form of basal cell carcinoma (BCC) on the face. Accurately recognizing more high-risk BCCs allows patients to receive the most effectiv
- Researchers Identify Distinct Sleep Types and Their Impact on Long-Term Healthhttps://reachmd.com/news/researchers-identify-distinct-sleep-types-and-their-impact-on-long-term-health/2462298/UNIVERSITY PARK, Pa. — Poor sleep habits are strongly associated with long-term chronic health conditions, according to decades of research. To better understand this relationship, a team led by researchers in Penn State’s College of Health and Human Development identified four distinct
- Could a Common Diabetes Drug Ease Knee Osteoarthritis Pain—and Delay Surgery?https://reachmd.com/news/drug-repurposing-diabetes-medication-for-managing-knee-osteoarthritis-pain/2474341/In an era where repurposing familiar drugs has become a promising frontier in medicine, metformin—a stalwart in type 2 diabetes care—is stepping into an unexpected new role. Recent clinical trials suggest that this decades-old medication may significantly reduce kn
- Integrating Social Determinants and Therapeutic Innovations in Diabetes Managementhttps://reachmd.com/news/integrating-social-determinants-and-therapeutic-innovations-in-diabetes-management/2476032/Diabetes management is as much about understanding social contexts as it is about leveraging the latest medical advancements. Unpacking these layers is critical in shaping effective and equitable healthcare strategies. Social determinants like neighborhood deprivation exert a measura